5-Amino-1MQ 5mg
NNMT Inhibitor for Fat Cell Shrinkage and Metabolic Research
5-Amino-1MQ is a small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that blocks fat cell expansion by increasing cellular NAD+ and SAM levels, reducing adipocyte size without increasing adipocyte number.
NNMT Inhibitor for Fat Cell Shrinkage and Metabolic Research
NNMT is highly expressed in obese adipose tissue; its inhibition by 5-Amino-1MQ shifts methylation potential toward adipocyte differentiation suppression, reducing fat cell size and improving metabolic markers in preclinical models.
As one of the most studied compounds in the metabolic & fat loss research space, 5-Amino-1MQ has attracted sustained scientific interest across NNMT pathway research, Adipocyte biology, NAD+ metabolism studies. Peer-reviewed evidence indicates that reduces adipocyte size in obese mouse models, which has positioned 5-Amino-1MQ as a reference standard for researchers exploring nnmt pathway research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
5-Amino-1MQ Documented Benefits: 3 Documented Mechanisms
Adipocyte Shrinkage
Inhibits NNMT to reduce fat cell size and lipid accumulation in adipose tissue.
NAD+ Elevation
NNMT inhibition increases cellular NAD+ and SAM, activating sirtuin longevity pathways.
Metabolic Improvement
Reduces adiposity and improves metabolic markers in diet-induced obesity models.
How 5-Amino-1MQ Works: Molecular Mechanism & Pathway
NNMT (nicotinamide N-methyltransferase) inhibitor increasing cellular SAM and NAD+ levels to suppress adipocyte expansion via sirtuin and methylation pathway activation.
The 3 primary research pathways identified for 5-Amino-1MQ — Adipocyte Shrinkage, NAD+ Elevation, Metabolic Improvement — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that nNMT expression correlates with obesity and T2D, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, 5-Amino-1MQ's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
5-Amino-1MQ is routinely studied alongside NAD+ and 5-Amino-1MQ in metabolic & fat loss-focused compound panels. Researchers investigating nnmt pathway research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that nAD+ and SAM elevation distinguishes from other fat loss compounds has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All 5-Amino-1MQ research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Reduces adipocyte size in obese mouse models
- NNMT expression correlates with obesity and T2D
- NAD+ and SAM elevation distinguishes from other fat loss compounds
Ideal For
- NNMT pathway research
- Adipocyte biology
- NAD+ metabolism studies
- Metabolic obesity research
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on 5-Amino-1MQ. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Reduces adipocyte size in obese mouse models
NNMT expression correlates with obesity and T2D
NAD+ and SAM elevation distinguishes from other fat loss compounds
Third-Party Verified Every Batch
Each vial of 5-Amino-1MQ is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
